Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
D000243:Adenosine Deaminase / Q000096:biosynthesis; D058892:Adenosine Deaminase Inhibitors; D001381:Azepines / Q000494:pharmacology*; D001693:Biological Transport, Active / Q000187:drug effects; D002460:Cell Line; D003070:Coformycin / Q000031:analogs & derivatives / Q000494:pharmacology*; D004109:Dilazep / Q000494:pharmacology*; D004176:Dipyridamole / Q000494:pharmacology*; D004793:Enzyme Reactivators / Q000494:pharmacology; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D007938:Leukemia / Q000201:enzymology; D008223:Lymphoma / Q000201:enzymology; D008433:Mathematics; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D009705:Nucleosides / Q000378:metabolism / Q000502:physiology*; D015649:Pentostatin; D010974:Platelet Aggregation / Q000187:drug effects*; D012263:Ribonucleosides / Q000494:pharmacology*
D058892:Adenosine Deaminase Inhibitors; D001381:Azepines; D004793:Enzyme Reactivators; D009705:Nucleosides; D012263:Ribonucleosides; D003070:Coformycin; D015649:Pentostatin; D004176:Dipyridamole; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase; D004109:Dilazep